Configuration and method for fixation of a filter to a catheter
11266490 · 2022-03-08
Assignee
Inventors
Cpc classification
A61M25/0009
HUMAN NECESSITIES
Y10T29/49865
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B29C66/304
PERFORMING OPERATIONS; TRANSPORTING
A61F2/0108
HUMAN NECESSITIES
B29C65/02
PERFORMING OPERATIONS; TRANSPORTING
B29C66/52272
PERFORMING OPERATIONS; TRANSPORTING
A61F2/013
HUMAN NECESSITIES
Y10T29/49817
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
B29C66/348
PERFORMING OPERATIONS; TRANSPORTING
B29C66/532
PERFORMING OPERATIONS; TRANSPORTING
A61M2025/0681
HUMAN NECESSITIES
A61F2/014
HUMAN NECESSITIES
B29C65/10
PERFORMING OPERATIONS; TRANSPORTING
B29C65/68
PERFORMING OPERATIONS; TRANSPORTING
International classification
Abstract
An attachment configuration for a vascular filter assembly including a self-expanding filter member attached to a catheter body and constrained from expansion in a first configuration by a constraining sheath is presented. The attachment configuration includes an outer tube of material that is overlaid over an end of the filter member and bonded to the catheter body through cutouts disposed through the end of the filter member.
Claims
1. A medical device coupled to a catheter, comprising: a. a generally tubular coupling projecting proximally from the medical device and circumferentially engaged with the catheter, the generally tubular coupling having a proximal end and a distal end and further comprising a first plurality of cutouts positioned at one of or both the proximal end or distal end and positioned about a circumferential axis of the generally tubular coupling and a second plurality of cutouts in an intermediate section and positioned about the circumferential axis of the generally tubular coupling, the first plurality of cutouts and the second plurality of cutouts being geometrically deformable to allow for diametric expansion diametric compression of the generally tubular coupling onto the catheter; and b. a circumferentially compressive member disposed concentrically about the generally tubular coupling and over the first plurality of cutouts and the second plurality of cutouts, and engaged with the generally tubular coupling and the catheter through at least some of the first plurality of cutouts or second plurality of cutouts.
2. The medical device of claim 1, wherein the circumferentially compressive member is made of a first material and the catheter is made of a second material and the first material and the second material are reflow joined.
3. The medical device of claim 2, wherein the first material and the second material are polymeric materials.
4. The medical device of claim 3, wherein the first material and the second material are the same polymeric material.
5. The medical device of claim 2, wherein the first plurality of cutouts and second plurality of cutouts are selected from the group consisting of: polygonal, circular, elliptical, open-ended circular, semi-circular, zig-zag, sinusoidal, coiled, and spaced line.
6. The medical device of claim 2, wherein the first plurality of cutouts are configured with a width W extending generally along a longitudinal axis of the proximal end and a height H extending generally along a circumferential axis of the proximal end, wherein the width W of the cutouts is greater than the height H of the first plurality of cutouts and second plurality of cutouts.
7. The medical device of claim 1, wherein the first plurality of cutouts further comprises substantially non-linear cutouts.
8. The medical device of claim 1, wherein the second plurality of cutouts further comprises substantially linear helically-oriented cutouts extending along the circumferential axis of the generally tubular coupling.
9. The medical device of claim 8, wherein the substantially linear helically-oriented cutouts terminate in continuity with the first plurality of cutouts.
10. The medical device of claim 1, wherein the first plurality of cutouts further comprise substantially tear-drop shaped cutouts.
11. The medical device of claim 10, further comprising a plurality of projections each comprising a substantially quadrilateral proximal portion and a substantially looped distal portion, the substantially looped distal portion forming the substantially tear-drop shaped cutouts.
12. The medical device of claim 11, further comprising substantially linear members projecting from the substantially quadrilateral proximal portion and coextensive with the medical device.
13. A method for attaching a proximal end of a medical device to a catheter, comprising: a. disposing a thin tube over a catheter body and over at least a portion of the proximal end of the medical device, wherein the proximal end includes a plurality of cutouts; b. disposing a circumferentially compressive member coaxially over the thin tube; and c. joining the thin tube to the catheter body through the plurality of cutouts to attached the proximal end of the medical device to the catheter body.
14. The method of claim 13, wherein step c, further comprises the step of reflowing a first material of the thin tube with a second material of the catheter body.
15. The method of claim 13, further comprising the step of forming the plurality of cutouts in a shape selected from the group consisting of: polygonal, circular, elliptical, open-ended circular, semi-circular, zig-zag, sinusoidal, coiled, and spaced line.
16. The method of claim 13, further comprising the step of configuring the plurality of cutouts to have a width W extending generally along a longitudinal axis of the proximal end and a height H extending generally along an axial axis of the proximal end, wherein the width W of the cutouts is greater than the height H of the plurality of cutouts.
17. The method of claim 13, wherein the circumferentially compressive member is a heat shrink tube.
18. The method of claim 13, further comprising removing the circumferentially compressive member from the thin tube after the joining step is completed.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
(7) The foregoing and other features and advantages of the invention are apparent from the following detailed description of exemplary embodiments, read in conjunction with the accompanying drawings; wherein like structural or functional elements may be designated by like reference numerals.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
(8) In the accompanying Figures like structural or functional elements are designated by like reference numerals, e.g., 16, 116, 216, 316, 416 represent similar structural or functional elements across different embodiments disclosed herein.
(9) As used in this application, unless otherwise specifically stated, the terms “proximal” and “distal” are intended to refer to positions relative to a longitudinal axis of the VFA. Those skilled in the art will understand that the VFA has a distal end which is first inserted into a patient and a proximal end which opposite the distal end. Additionally, the terms “inferior” or “inferiorly” are intended to refer to the anatomic orientation of being in a direction away from the patient's head while the terms “superior” or “superiorly” are intended to refer to the anatomic orientation of being toward the patient's head.
(10) The embodiments disclosed herein may be configured for either a femoral approach or a jugular approach to the inferior vena cava. Vena cava filters are typically deployed infrarenaly, but may also be deployed suprarenaly. It will be understood that within the inferior vena cava blood flow is superior, i.e., toward a patients head. Thus, in all embodiments, the vena cava filter will be positioned so that it opens inferiorly, i.e., away from the patient's head and toward the direction of the blood flow. It will be appreciated, therefore, that in the embodiments disclosed herein, the vena cava filter will have a different axial orientation on the central access catheter depending upon whether the device is intended for use in a femoral approach or a jugular approach.
(11) The most common imaging modality used for filter insertion is fluoroscopy, performed either in an interventional suite or an operating room. Bedside placement of filters has inherent advantages, particularly for critically ill patients in intensive care settings where transport can be avoided. Portable fluoroscopy, surface duplex ultrasound and intravascular ultrasound (IVUS) have all been used to assist with bedside filter placement.
(12) Referring to
(13) The filter member 104 may be slidably or fixedly attached to the catheter body 102 or may be removably coupled to the catheter body 102 for deployment as either a permanent filter or as a temporary and retrievable vena cava filter. Removable coupling of the filter member 104 to the catheter body 102 may be accomplished with a variety of release and retrieval mechanisms operably associated with the catheter body 102. Non-limiting examples of such release and retrieval mechanisms are disclosed, for example, in Angel U.S. Patent Application Publication No. 2009/0062840 and Angel et al. U.S. Patent Application Publication No. 2010/0217304, incorporated by reference in their entirety herein.
(14) Referring to
(15) Referring to
(16) Again referring to
(17) Referring to
(18) A proximal hub 148 may be coupled to a proximal end 150 of the catheter body 102. The proximal hub 148 and the distal hub 134 may be removably engageable with each other. A plurality of fluid lines, for example, fluid lines L1, L2, L3, L4, may communicate with the proximal hub 148, as illustrated in
(19) Referring to
(20) In one embodiment, the material of a thin tube 406 (See
(21) The plurality of cutouts 408 include a width W extending generally along the longitudinal axis of the proximal end 404 and a height H extending generally along the axial axis of the proximal end 404, as shown in
(22) In one embodiment, the plurality of cutouts 408 are longitudinally disposed throughout the proximal end 404 of the filter, that is the cutouts 408 extend generally parallel along the longitudinal axis. The longitudinal extension of the cutouts 408 provides a series of longitudinal rows of cutouts 410, i.e. a first longitudinal row of cutouts 410a, a second longitudinal row of cutouts 410b, and a third longitudinal row of cutouts 410c, as shown in
(23) Also, the plurality of cutouts 408 may be disposed in a series of axial column of cutouts 420, i.e. a first axial column of cutouts 420a, a second axial column of cutouts 420b, and a second axial column of cutouts 420c, as shown in
(24)
(25)
(26)
(27)
(28)
(29) Referring now to all embodiments, the attachment configuration 402 is created by a thermal bonding process including first inserting polymer coated metal wires into a single lumen of the single lumen catheter body 102 or into multiple lumens of the multilumen catheter body 102. In one embodiment, the polymer coating for the metal wires is polytetrafluorethylene (PTFE), although other polymers may be used as indicated below. The polymer coated metal wires placed into the lumen or lumens inhibit closure or filling of the lumen or lumens in the rest of the process and therefore function to maintain patency of the lumen or lumens.
(30) Next, a thin tube 406 is coaxially disposed over the catheter body 102 and coaxially over at least a portion of the proximal end 404 of the filter member 104 as illustrated in
(31) A polyethylene terephthalate (PET) heat shrink tube (not shown) is disposed over the thin tube 406. Alternative polymer heat shrink tubes may be used, such as fluorinated ethylene propylene (FEP) provided that the polymer heat shrink tube is not the same material as the thin tube 406 or the catheter body 102. In one embodiment, the thin tube is fused to the catheter body 102 through the plurality of cutouts 408 using, for example, hot air as provided from a hot air nozzle. In other embodiments, the fusing may be supplied in alternative ways such as a thermal bonder, thermoplastics, and the like. For portions of the proximal end that are not to be bonded by the thin tube 406, a heat shield may be used to protect such areas of the proximal end 404 to prevent fusing. Heating the attachment configuration 402 causes the material of the thin tube 406 and the material of the catheter body 102 to melt together. In one embodiment, the melting together of the thin tube 406 and the catheter body 102 causes contact and bonding therebetween through the cutouts 408. Effectiveness of such contact and bonding may be increased in embodiments where the thin tube 406 and the catheter body 102 are made of the same material, which upon melting can flow together through the cutouts 408 into a seamless monolithic structure that encapsulates the end 404 of the filter 104 as illustrated in
(32) The catheter body 102 in the region of the attachment configuration 402 may be the single lumen catheter body 102 as illustrated in
(33) Alternative polymeric materials may be included for the thin tube 406, such as, for example, polytetrafluoroethylene (PTFE), ethylene tetrafluoroethylene (ETFE), fluorinated ethylene propylene (FEP), polyoxymethylene (POM, for example, as sold under the trademark DELRIN® available from DuPont), polybutylene terephthalate (PBT), polyether block ester, polyurethane, polypropylene (PP), polyvinylchloride (PVC), polyether-ester (for example, a polyether-ester elastomer as sold under the trademark ARNITEL® available from DSM Engineering Plastics), polyester (for example, a polyester elastomer as sold under the trademark HYTREL® available from DuPont), polyamide (for example, as sold under the trademark DURETHAN® available from Bayer or as sold under the trademark CRISTAMID® available from Elf Atochem), elastomeric polyamides, block polyamide/ethers, polyether block amide (PEBA, for example, as sold under the trade name PEBAX® available from Arkema, Inc.), silicones, polyethylene (PE), Marlex high-density polyethylene, Marlex low-density polyethylene, linear low density polyethylene, polyethylene terephthalate (PET), polyetheretherketone (PEEK), polyimide (PI), polyetherimide (PEI), polyphenylene sulfide (PPS), polyphenylene oxide (PPO), polysulfone, nylon, nylon-12 (as sold under the trademark GRILAMID® available from EMS American Grilon), perfluoro(propyl vinyl ether) (PFA), ethylene vinyl alcohol, polyolefin, polystyrene, epoxy, polyvinylidene chloride (PVdC), polycarbonates, ionomers, biocompatible polymers, other suitable materials, or mixtures, combinations, copolymers thereof, polymer/metal composites, and the like. Alternatively, the thin tube 406 may be fabricated from shape memory materials, including shape memory metals and shape memory polymers (“SMM”).
(34) The filter member 104 and the proximal end 404 may be fabricated of biocompatible materials, such as shape memory metal alloys, superelastic materials or elastic materials, including, without limitation, titanium, vanadium, aluminum, nickel, tantalum, zirconium, chromium, silver, gold, silicon, magnesium, niobium, scandium, platinum, cobalt, palladium, manganese, molybdenum and alloys thereof, such as zirconium-titanium-tantalum alloys, cobalt-chromium-molybdenum alloys, nitinol, and stainless steel. Alternatively, biocompatible polymers may be used to fabricate the filter member 104 and the proximal end 404. The plurality of cutouts may be formed by laser cutting, wet or dry etching, and similar methods for creating cutouts in metal materials.
(35) In addition, a placement sensor may be coupled to the proximal end 404 to determine the degree of attachment for the configuration 402. Such a placement sensor may provide indications on whether the proximal end 404 is moving along the longitudinal axis of the catheter body 102 after affixation. If movement of the proximal end 404 is detected by the user, the user may then retract the catheter body as to prevent the filter member 104 from being retracted to the first configuration 200 or the filter member being dislodged in the patient.
(36) While the embodiments disclosed herein are not limited to specific dimensional sizes of the catheter body 102, the sheath 106, or any lumen diameter or port dimension, an exemplary outer diameter size of the sheath 106 is between about 6 Fr (2.0 mm) and about 9 Fr (3.0 mm). An exemplary outer diameter size of the catheter body 102 is between about 4 Fr (1.3 mm) and 7 Fr (2.4 mm).
(37) An attachment configuration for a vascular filter assembly (“VFA”) including a self-expanding filter member attached to a catheter body and constrained from expansion in a first configuration by a low profile constraining sheath is presented. The attachment configuration is simple to produce and provides an effective and reliable bond between the filter member and the catheter body.
(38) Vena cava filter placement frequently occurs concomitantly with central access line placement or in critically ill patients that already have a central access line in place. Heretofore, however, there have been no devices which combine the function of a central access catheter and a removable vena cava filter.
(39) The embodiments disclosed herein benefit from an improved method for coupling a multi-lumen catheter to a vena cava filter such that the multi-lumen catheter is useful both as a central venous access catheter for administration of intravenous fluids, bioactive agents, contrast agents, flushing agents, pressurized fluids for mechanical thrombolysis and/or withdrawal of blood samples and for capture of thrombus or emboli.
(40) The embodiments disclosed herein further benefit from a filter geometry in which the proximal portion of the filter, relative to the axis of blood flow, has larger interstitial openings to permit thrombus or embolic material to flow into the filter, while the distal portion of the filter, again relative to the axis of blood flow, has relatively smaller interstitial openings that capture the thrombus or embolic material within the filter. Another way to view this aspect is that the structure of the filter includes a greater open surface area exposed to the flow of embolic material into the filter at its proximal end, while the distal end has smaller open surface area exposed to the flow of embolic material to capture the embolic material in the distal end of the filter member. More specifically, regardless of whether the embodiments disclosed herein is delivered by a jugular approach or a femoral approach, the filter geometry is such that the larger interstitial openings of the filter are positioned inferiorly along a longitudinal axis of the filter. The embodiments disclosed herein also benefit from combining the functions of an inferior vena cava (IVC) filter and a multilumen central venous catheter. The embodiments disclosed herein may be placed in the inferior vena cava via the femoral vein for the prevention of PE, as well as access to the central venous system.
EXAMPLES
(41) A study compared the ease of in vitro placement, retrieval, deployment, and clot-trapping effectiveness a Vena Cava Filter Catheter (VCFC) utilizing the embodiments disclosed herein compared to other retrievable IVC filters. (Angel L, Guerra R, Atkinson E, et al. In Vitro Placement and Effectiveness of the Angel™ Vena Cava Filter Catheter), incorporated by reference herein.
(42) The study was conducted in a vena cava simulator with tubing diameters of 16 mm, 19 mm, 25 mm and 30 mm. Human blood has a mean density of 1.055 g/mL and a mean viscosity of 0.035 St at a mean temperature of 37 C. Therefore, the vena cava simulator mimicked physiological conditions by using a blood analog aqueous solution, composed of 52% glycerin by weight with a density of 1.12 g/ML and a viscosity of 0.032 St that was circulated at 37±2° C.
(43) The filter was expanded as the outer sheath was pulled back and secured in position. The filter was retrieved by reversing the process and collapsing the filter as the multilumen catheter was pulled back into the outer sheath. The filter was tested with 150 cylindrical clots that simulated emboli of four different sizes: 3×5 mm, 3×10 mm, 5×10 mm and 5×20 mm. The clot-trapping effectiveness of the VCFC was compared to other retrievable IVC filters including the Cook Gunther Tulip, Bard Recovery, and Bard G2.
(44) The VCFC utilizing the embodiments disclosed herein was successfully deployed 24 times at various vena cava diameters. All the tested filters were deployed in the required area with full apposition against the wall of the simulated vena cava at all times. No migration was observed post deployment or during the clot capture efficiency testing. Filter efficiency increased proportionally to the cylindrical clot size and inversely to the test tube inner diameter. The clot capturing rate of the VCFC utilizing the embodiments disclosed herein was similar to that of the Tulip, Recovery, and G2 filters at an IVC diameter of 16 mm and 19 mm, but was superior in capturing small clots at a diameter of 25 mm (p<0.001). This initial evaluation of the effectiveness of the VCFC utilizing the embodiments disclosed herein shows that it is as effective as predicate filters at various vena cava diameters. The VCFC utilizing the embodiments disclosed herein addresses the important limitations of predicate vena cava filters. Specifically, the VCFC utilizing the embodiments disclosed herein allows for bedside insertion and retrieval for critically ill patients by combining a multilumen central venous catheter and a truly retrievable vena cava filter. Further details on the study of the ease of in vitro placement, retrieval, deployment, and clot-trapping effectiveness the Vena Cava Filter Catheter (VCFC) utilizing the embodiments disclosed herein may be found in Angel L, Guerra R, Atkinson E, et al. In Vitro Placement and Effectiveness of the Angel™ Vena Cava Filter Catheter.
(45) It will be appreciated by those skilled in the art that changes could be made to the embodiments described hereinabove without departing from the broad concepts disclosed therein. It is understood, therefore, that this disclosure is not limited to the particular embodiments disclosed, but it is intended to cover modifications that may include a combination of features illustrated in one or more embodiments with features illustrated in any other embodiments. Various modifications, equivalent processes, as well as numerous structures to which the present disclosure may be applicable will be readily apparent to those of skill in the art to which the present disclosure is directed upon review of the present specification. Accordingly, this description is to be construed as illustrative only and is presented for the purpose of enabling those skilled in the art to make and use the attachment configuration described herein and to teach the best mode of carrying out the same.